sellWeak
Andrew Spaventa sold $3,629 of OMIC
Chief Executive Officer at Singular Genomics Systems, Inc.. 180 shares at an average of $20.16, traded Dec 16, 2024, filed Dec 17, 2024.
Warning score
15Value
$3,629
180 shares
Holdings after
631
-22% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$4k at market
- +5Share of holdings soldSold 22% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-137425, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 15, 2024 | MOption exercise Common Stock | +486 | - | - | 811 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock | -180 | $20.16 | $3,629 | 631 | Dec 17, 2024 |
| Dec 16, 2024 | GGift Common Stock | -306 | $0.00 | $0 | 325 | Dec 17, 2024 |
| Dec 16, 2024 | GGift Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +306 | $0.00 | $0 | 141,793 | Dec 17, 2024 |
| Dec 15, 2024 | MOption exercise Restricted Stock Unitsderivative | -486 | $0.00 | $0 | 4,374 | Dec 17, 2024 |
Related signals
Other insiders at Singular Genomics Systems, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | OMICsell Singular Genomics Systems, Inc. | Andrew Spaventa Chief Executive Officer | $16k 695 shares | -31% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.